Ö. FİDAN Et Al. , "Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing," MOLECULAR DIVERSITY , vol.27, no.1, pp.463-475, 2023
FİDAN, Ö. Et Al. 2023. Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing. MOLECULAR DIVERSITY , vol.27, no.1 , 463-475.
FİDAN, Ö., Mujwar, S., & Kciuk, M., (2023). Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing. MOLECULAR DIVERSITY , vol.27, no.1, 463-475.
FİDAN, ÖZKAN, Somdutt Mujwar, And Mateusz Kciuk. "Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing," MOLECULAR DIVERSITY , vol.27, no.1, 463-475, 2023
FİDAN, ÖZKAN Et Al. "Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing." MOLECULAR DIVERSITY , vol.27, no.1, pp.463-475, 2023
FİDAN, Ö. Mujwar, S. And Kciuk, M. (2023) . "Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing." MOLECULAR DIVERSITY , vol.27, no.1, pp.463-475.
@article{article, author={ÖZKAN FİDAN Et Al. }, title={Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing}, journal={MOLECULAR DIVERSITY}, year=2023, pages={463-475} }